Have You Heard The News??
GTBP has been a company we’ve followed along closely and Friday afternoon we saw a surge of trading momentum kick into high gear. In fact by the closing bell, GTBP had rallied by more than 15% and we feel that this momentum could just be gtting started!
InCaseYouMissedIt: GT Biopharma (GTBP) Announces Appointment of Shawn M Cross as Chairman and Chief Executive Officer
GT Biopharma, Inc. (GTBP) (GTBP.PA) (“GT” or the “Company”), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel cancer immunotherapy products as well as central nervous system treatments, today announced that Shawn M. Cross will become Chairman and Chief Executive Officer effective February 15, 2018.
An affiliate of BiotechStocks.com (MAPH ENTERPRISES LLC) has been compensated $150,000.00 by a GT Biopharma Inc. for a period beginning Jan 1, 2018 and ending Feb. 1, 2018 now extended till March 1, 2018 for an additional $250,000 paid for by GT Biopharma Inc. to publicly disseminate information about (GTBP). We own zero shares.